AMENDMENT TO INVESTMENT AGREEMENTInvestment Agreement • June 2nd, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
This Amendment to the Investment Agreement (this “Amendment”) is made as of June 1, 2017 (the “Effective Date”), by and between Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Company”) and Ernst Welmers (the “Investor”). Capitalized terms used but not defined herein have the meanings given to them in the Investment Agreement (as defined below).
AMENDMENT TO AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • June 2nd, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
This Amendment to the Amended and Restated Consulting Agreement (this “Amendment”) is made as of June 1, 2017 (the “Effective Date”), by and between Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Company”) and LYL Holdings Inc. (the “Consultant”). Capitalized terms used but not defined herein have the meanings given to them in the Consulting Agreement (as defined below).
